Goodman Campbell Brain and Spine, Indiana University Department of Neurological Surgery, Indianapolis, USA.
World Neurosurg. 2013 Nov;80(5):654.e1-8. doi: 10.1016/j.wneu.2012.08.007. Epub 2012 Sep 25.
Malignant peripheral nerve sheath tumors are rare, and intracranial occurrences are even more rare. Treatment strategies have varied widely. This article reports the first case of a malignant peripheral nerve sheath tumor of the abducens nerve and provides a literature review that includes 61 cases of intracranial malignant peripheral nerve sheath tumors. Data were analyzed based on age, sex, treatment, survival, immunohistochemical staining, location, tumor grade, and neurofibromatosis association. These tumors more often affect male persons, and the patients affected have a mean age of 39 years. Most patients underwent subtotal or gross total resection and radiation. Intracranial location varied, but most tumors occurred in the cerebellopontine angle. The literature shows that intracranial malignant peripheral nerve sheath tumors are a heterogeneous group. Their association with neurofibromatosis is less clear than that of their extracranial counterparts. Prognosis is poor, but surgical resection and radiation can enhance chances for longer survival. Our aim was to elucidate information about these tumors.
A 30-year-old woman presented with a 6-month history of headaches and diplopia.
Neurological examination revealed no focal deficit. Imaging revealed a heterogeneously enhancing retroclival mass without bony destruction. The tumor originated from the ipsilateral abducens nerve and extended into the Dorello canal; it adhered to the brainstem and cranial nerves. Pathology was consistent with low-grade malignant peripheral nerve sheath tumor.
At 3-month follow-up, the patient walked with a cane with no further deficits except mild ataxia, which resolved within 6 months. Magnetic resonance imaging revealed a small residual tumor adherent to the basilar artery. At 1-year follow-up and after ocular surgery to correct lateral rectus palsy, the patient was neurologically intact.
恶性外周神经鞘瘤罕见,颅内发生更为罕见。治疗策略差异很大。本文报道首例展神经恶性外周神经鞘瘤病例,并对包括 61 例颅内恶性外周神经鞘瘤的文献进行了综述。根据年龄、性别、治疗方法、生存情况、免疫组织化学染色、位置、肿瘤分级和神经纤维瘤病相关性对数据进行了分析。这些肿瘤更常影响男性,受影响的患者平均年龄为 39 岁。大多数患者接受了次全或大体全切除术和放疗。颅内位置不一,但大多数肿瘤发生在桥小脑角。文献表明,颅内恶性外周神经鞘瘤是一组异质性肿瘤。它们与神经纤维瘤病的相关性不如其颅外肿瘤明显。预后较差,但手术切除和放疗可以提高生存机会。我们的目的是阐明这些肿瘤的信息。
一名 30 岁女性,因头痛和复视病史 6 个月就诊。
神经系统检查未发现局灶性缺陷。影像学显示后颅窝不均匀强化肿块,无骨破坏。肿瘤起源于同侧展神经,延伸至 Dorello 管;它与脑干和颅神经粘连。病理符合低度恶性外周神经鞘瘤。
在 3 个月的随访中,患者用拐杖行走,除了轻微的共济失调外,没有其他缺陷,6 个月内恢复正常。磁共振成像显示基底动脉上有一个小的残留肿瘤,与动脉粘连。在 1 年的随访和纠正外直肌麻痹的眼部手术后,患者神经功能完整。